Related Experiment Video
Updated: Aug 17, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Androgen receptor mutations identified in prostate cancer and androgen insensitivity syndrome display aberrant ART-27
Wenhui Li1, Claudio N Cavasotto, Timothy Cardozo
1Department of Microbiology, New York University Cancer Institute, New York University School of Medicine, New York, New York 10016, USA.
Abstract:
The transcriptional activity of the androgen receptor (AR) is modulated by interactions with coregulatory molecules. It has been proposed that aberrant interactions between AR and its coregulators may contribute to diseases related to AR activity, such as prostate cancer and androgen insensitivity syndrome (AIS); however, evidence linking abnormal receptor-cofactor interactions to disease is scant. ART-27 is a recently identified AR N-terminal coactivator that is associated with AR-mediated growth inhibition. Here we analyze a number of naturally occurring AR mutations identified in prostate cancer and AIS for their ability to affect AR response to ART-27. Although the vast majority of AR mutations appeared capable of increased activation in response to ART-27, an AR mutation identified in prostate cancer (AR P340L) and AIS (AR E2K) show reduced transcriptional responses to ART-27, whereas their response to the p160 class of coactivators was not diminished. Relative to the wild-type receptor, less ART-27 protein associated with the AR E2K substitution, consistent with reduced transcriptional response. Surprisingly, more ART-27 associated with AR P340L, despite the fact that the mutation decreased transcriptional activation in response to ART-27. Our findings suggest that aberrant AR-coactivator association interferes with normal ART-27 coactivator function, resulting in suppression of AR activity, and may contribute to the pathogenesis of diseases related to alterations in AR activity, such as prostate cancer and AIS.
Insights
Aberrant androgen receptor (AR) interactions with coactivators like ART-27 may drive diseases such as prostate cancer. Specific AR mutations impair ART-27 function, suggesting a role in disease pathogenesis.
Area of Science:
- Molecular Biology
- Genetics
- Endocrinology
Background:
- Androgen receptor (AR) transcriptional activity relies on coregulatory molecules.
- Dysfunctional AR-coregulator interactions are implicated in diseases like prostate cancer and androgen insensitivity syndrome (AIS), but direct evidence is limited.
- ART-27 is a novel AR N-terminal coactivator linked to AR-mediated growth inhibition.
Purpose of the Study:
- To investigate how naturally occurring AR mutations found in prostate cancer and AIS affect the receptor's response to the coactivator ART-27.
- To determine if altered AR-ART-27 interactions contribute to the pathogenesis of AR-related diseases.
Main Methods:
- Analysis of AR mutations from prostate cancer and AIS patients.
- Assessing the transcriptional response of mutated ARs to ART-27 and p160 coactivators.
- Quantifying ART-27 protein association with wild-type and mutant ARs.
Main Results:
- Most AR mutations enhanced transcriptional activity in response to ART-27.
- AR mutations P340L (prostate cancer) and E2K (AIS) exhibited reduced transcriptional responses to ART-27, unlike their response to p160 coactivators.
- ART-27 binding was reduced with AR E2K but surprisingly increased with AR P340L, despite decreased transcriptional activity.
Conclusions:
- Aberrant AR-coactivator interactions, specifically with ART-27, can interfere with coactivator function and suppress AR activity.
- These disruptions in ART-27 coactivation may play a role in the development of prostate cancer and AIS.
- Understanding these molecular mechanisms is crucial for disease pathogenesis research.
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Abnormal Proliferation
Co-activators and Co-repressors
Co-activators and Co-repressors
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...